Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-130480

Options or other derivatives

  • Director acquired 6,632 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mehra Anand Director 2016-06-29 Grant or award · Stock Option (right to buy) +6,632 6,632 D
Loading xslF345X03/doc4.xml…